Adjuvant ipilimumab versus placebo after complete resection of high-risk stage III melanoma (EORTC 18071): a randomised, double-blind, phase 3 trial by Eggermont, Alexander M M, Prof, Chiarion-Sileni, Vanna, MD, Grob, Jean-Jacques, Prof, Dummer, Reinhard, Prof, Wolchok, Jedd D, MD, Schmidt, Henrik, MD, Hamid, Omid, MD, Robert, Caroline, Prof, Ascierto, Paolo A, Prof, Richards, Jon M, MD, Lebbé, Céleste, Prof, Ferraresi, Virginia, MD, Smylie, Michael, MD, Weber, Jeffrey S, MD, Maio, Michele, MD, Konto, Cyril, MD, Hoos, Axel, MD, de Pril, Veerle, MSc, Gurunath, Ravichandra Karra, MD, de Schaetzen, Gaetan, PhD, Suciu, Stefan, PhD, Testori, Alessandro, MD

Get full text

Ipilimumab 10 mg/kg versus ipilimumab 3 mg/kg in patients with unresectable or metastatic melanoma: a randomised, double-blind, multicentre, phase 3 trial by Ascierto, Paolo A, Dr, Del Vecchio, Michele, MD, Robert, Caroline, Prof, Mackiewicz, Andrzej, Prof, Chiarion-Sileni, Vanna, MD, Arance, Ana, MD, Lebbé, Céleste, Prof, Bastholt, Lars, MD, Hamid, Omid, MD, Rutkowski, Piotr, Prof, McNeil, Catriona, MD, Garbe, Claus, Prof, Loquai, Carmen, MD, Dreno, Brigitte, Prof, Thomas, Luc, Prof, Grob, Jean-Jacques, Prof, Liszkay, Gabriella, Prof, Nyakas, Marta, MD, Gutzmer, Ralf, Prof, Pikiel, Joanna, MD, Grange, Florent, MD, Hoeller, Christoph, MD, Ferraresi, Virginia, MD, Smylie, Michael, MD, Schadendorf, Dirk, Prof, Mortier, Laurent, Prof, Svane, Inge Marie, MD, Hennicken, Delphine, MSc, Qureshi, Anila, MD, Maio, Michele, MD

Get full text

Health-related quality of life with adjuvant ipilimumab versus placebo after complete resection of high-risk stage III melanoma (EORTC 18071): secondary outcomes of a multinational... by Coens, Corneel, MSc, Suciu, Stefan, PhD, Chiarion-Sileni, Vanna, MD, Grob, Jean-Jacques, Prof, Dummer, Reinhard, Prof, Wolchok, Jedd D, MD, Schmidt, Henrik, MD, Hamid, Omid, MD, Robert, Caroline, Prof, Ascierto, Paolo A, Prof, Richards, Jon M, MD, Lebbé, Celeste, Prof, Ferraresi, Virginia, MD, Smylie, Michael, MD, Weber, Jeffrey S, MD, Maio, Michele, MD, Bottomley, Andrew, PhD, Kotapati, Srividya, PharmD, de Pril, Veerle, Testori, Alessandro, MD, Eggermont, Alexander M M, Prof

Get full text

A population-based study of cutaneous melanoma in Alberta, Canada (1993-2002) by Metelitsa, Andrei I., MD, Dover, Douglas C., MSc, Smylie, Michael, MD, de Gara, Chris J., MBBS, MS, Lauzon, Gilles J., MD, PhD

Get full text

Ipilimumab monotherapy in patients with pretreated advanced melanoma: a randomised, double-blind, multicentre, phase 2, dose-ranging study by Wolchok, Jedd D, Dr, Neyns, Bart, MD, Linette, Gerald, MD, Negrier, Sylvie, Prof, Lutzky, Jose, MD, Thomas, Luc, Prof, Waterfield, William, MD, Schadendorf, Dirk, Prof, Smylie, Michael, Prof, Guthrie, Troy, MD, Grob, Jean-Jacques, Prof, Chesney, Jason, MD, Chin, Kevin, MD, Chen, Kun, PhD, Hoos, Axel, MD, O'Day, Steven J, MD, Lebbé, Celeste, Prof

Get full text

Results of Two Open-Label, Multicenter Phase II Studies of Docetaxel, Platinum Salts, and Trastuzumab in HER2-Positive Advanced Breast Cancer by Pegram, Mark D., Pienkowski, Tadeusz, Northfelt, Donald W., Eiermann, Wolfgang, Patel, Ravi, Fumoleau, Pierre, Quan, Eleonor, Crown, John, Toppmeyer, Deborah, Smylie, Michael, Riva, Alessandro, Blitz, Sandra, Press, Michael F., Reese, David, Lindsay, Mary-Ann, Slamon, Dennis J.

Get full text

Genome-Wide Single-Nucleotide Polymorphism Analysis Defines Haplotype Patterns in Mouse by Wiltshire, Tim, Pletcher, Mathew T., Batalov, Serge, Barnes, S. Whitney, Tarantino, Lisa M., Cooke, Michael P., Wu, Hua, Smylie, Kevin, Santrosyan, Andrey, Copeland, Neal G., Jenkins, Nancy A., Kalush, Francis, Mural, Richard J., Glynne, Richard J., Kay, Steve A., Adams, Mark D., Fletcher, Colin F.

Get full text